Related Experiment Video
Updated: May 5, 2026

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
15.7K
Prion, prionoids and infectious amyloid
1Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland.
Parkinsonism & Related Disorders
|November 23, 2013
Summary
All amyloid proteins form via a seeded nucleation mechanism. This process explains the long lag phase in neurodegenerative diseases like Alzheimer's and Parkinson's, suggesting precursor concentration and seeds influence disease onset.
Area of Science:
- Biochemistry
- Neuroscience
- Pathology
Background:
- Amyloid formation is a common pathway in various neurodegenerative disorders.
- These disorders, including Alzheimer's and Parkinson's, are often diseases of old age.
- The underlying molecular mechanism involves protein misfolding and aggregation.
Purpose of the Study:
- To elucidate the universal seeded nucleation mechanism of amyloid formation.
- To explain the long lag phase observed in sporadic neurodegenerative diseases.
- To propose how precursor concentration and seeding influence nucleation.
Main Methods:
- The study is based on a theoretical framework of seeded nucleation.
- It analyzes the epidemiological phenomenon of neurodegenerative diseases as diseases of old age.
- It makes predictions based on the proposed seeded nucleation model.
Main Results:
- All amyloids, regardless of sequence, form via a seeded nucleation mechanism.
- This mechanism involves oligomeric seeds nucleating precursor proteins into beta-sheet structures.
- Increased precursor concentration or seeds can shorten the lag phase.
Conclusions:
- The seeded nucleation mechanism is a unifying principle for diverse protein misfolding disorders.
- The long lag phase in sporadic neurodegenerative diseases is explained by this mechanism.
- Understanding nucleation dynamics may offer therapeutic targets for age-related neurodegeneration.
Related Concept Videos
Amyloid Fibrils
10.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.3K
Amyloid Fibrils
5.2K
5.2K
Subviral Agents
940
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
940
Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29

